Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 36.4 1.62%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Operating Income 2011-2024 | SUPN

Annual Operating Income Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
46.1 M 86 M 174 M 149 M 144 M 99.5 M 54.2 M 20.8 M -5.28 M -61.9 M -42.2 M -37.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
174 M -61.9 M 52.2 M

Quarterly Operating Income Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
40.8 M 22.6 M -3.15 M - 8.14 M -17.6 M 5.18 M - -1.52 M 11.3 M 1.97 M - 32.6 M 34.1 M 13.2 M - 56.1 M 45.5 M 29 M 40.8 M 39.7 M 42.6 M 25.4 M 39.9 M 37.5 M 35.7 M 31.4 M 34.3 M 22.3 M 26.1 M 16.8 M 16.3 M 19.8 M 11.6 M 6.44 M - 5.08 M 3.84 M 4.03 M - -736 K 3.76 M -13.4 M - -17.2 M -15.5 M -17.9 M - -12.3 M -9.26 M -7.88 M - -9.92 M -8.4 M -9.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
56.1 M -17.9 M 13.5 M